Company / SG&A per Share
Zenas BioPharma, Inc. SG&A per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$1.28
FY2025
5-year range
$1.28 / $11.18
FY2023-FY2025
Trend
-88.2%
vs FY2024
Sector context
#106 of 210
Health Care
What the data says
At $1.28, Zenas BioPharma, Inc.'s sg&a per share ranks #105 of 210 in the Health Care sector. Improved from $11.18 to $1.28 over the past 2 years.
Based on SEC 10-K filings.
1.28 in FY2025.
Improved from $11.18 to $1.28 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#105 of 210 in Health CareTop 50% of 210This company $1.28 Sector average $40.75
▼
-96.9% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share decreased 88.2% year-over-year.
- Ranks #106 out of 210 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.51 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.28 | -88.2% |
| FY2024 | $10.85 | -2.9% |
| FY2023 | $11.18 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026